Investor relations

AIM Rule 26

Company information Documentation and announcement Securities information

Investors > AIM Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies and was last updated on 22 December 2025.
Description of the business
Names of the directors and biographical details
Corporate governance
Country of Incorporation and main country of operation: CelLBxHealth plc (formally ANGLE plc) is incorporated and registered in England and Wales under the Companies Act 1985. Registered No. 04985171. Main country of operation – United Kingdom.
Placing and admission to AIM (March 2004)
Memorandum of association
Articles of association
Annual and interim reports and financial statements
General meetings documentation
Company announcements
No. of Securities in issue: 1,139,402,658 ordinary shares of 0.05 pence each.
Significant shareholders
98.6% of securities are held in public hands.
There are no restrictions on the transfer of securities.
Exchanges: CelLBxHealth plc (formally ANGLE plc) is listed on the London Stock Exchange and shares are quoted and traded on the Alternative Investment Market (AIM: AGL). The Company has also established a Level 1 ADR Programme in the US and ADRs are traded on the OTCQX Market (OTCQX: ANPCY). CelLBxHealth plc (formally ANGLE plc) is not traded on any other exchanges or trading platforms.
CelLBxHealth plc (formally ANGLE plc) is subject to the UK City Code on takeovers and mergers.

Request a meeting with






    CelLBxHealth Logo
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.